Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 3, Issue 3, 2004, Pages 193-195

  Mckeon, D ^a   Day, A ^a   Parmar, J ^a   Alexander, G ^b   Bilton, D ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Cystic fibrosis liver disease; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; URSODEOXYCHOLIC ACID;

ADOLESCENCE; ADULT; ARTICLE; BLOOD LEVEL; CANCER SURGERY; CASE REPORT; CHRONIC LIVER DISEASE; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; LASER SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER TRANSPLANTATION; PATIENT REFERRAL; PREGNANCY; RISK FACTOR; TUMOR VOLUME; ULTRASOUND;

ADULT; CARCINOMA, HEPATOCELLULAR; CYSTIC FIBROSIS; FEMALE; HUMANS; LIVER NEOPLASMS;

EID: 4444356710     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.04.006     Document Type: Article

References (16)

1. Genyk Y.S. Quiros J.A. Jabbour N. Selby R.R. Thomas D.W. Liver transplantation in cystic fibrosis Curr. Opin. Pulm. Med. 7 6 2001 441-447
2. Kinnman N. Lindblad A. Housset C. Buentke E. Scheynius A. Strandvik B. et al. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis Hepatology 32 2 2000 334-340
3. Diwakar V. Pearson L. Beath S. Liver disease in children with cystic fibrosis Paediatr. Respir. Rev. 2 4 2001 340-349
4. Colombo C. Battezzati P.M. Crosignani A. Morabito A. Costantini D. Padoan R. et al. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome Hepatology 36 6 2002 1374-1382
5. Scott-Jupp R, Lama M, Tanner MS, Prevalence of liver disease in cystic fibrosis. Arch Dis Child. June 66 (6) 698-701
6. Colombo C. Apostolo M.G. Ferrari M. Seia M. Genoni S. Giunta A. et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis J. Pediatr. 124 3 1994 393-399
7. Lindblad A. Glaumann H. Strandvik B. Natural history of liver disease in cystic fibrosis Hepatology 30 5 1999 1151-1158
8. Noble-Jamieson G. Barnes N. Jamieson N. Friend P. Calne R. Liver transplantation for hepatic cirrhosis in cystic fibrosis J. R. Soc. Med. 89 Suppl. 27 1996 31-37
9. Lindblad A. Glaumann H. Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid secretion and liver morphology in cystic fibrosis-associated liver disease Hepatology 27 1998 166-174
10. Koch C. Cuppens H. Rainisio M. Madessani U. Harms H. Hodson M. et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations Pediatr. Pulmonol. 31 1 2001 1-12
11. Nousia-Arvanitakis S. Fotoulaki M. Economou H. Xefteri M. Galli-Tsinopoulou A. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease 5 J. Clin. Gastroenterol. 32 4 2001 324-328
12. Nguyen M.H. Keeffe E.B. Screening for hepatocellular carcinoma J. Clin. Gastroenterol. 35 5 Suppl. 2 2002 S86-S91
13. Montalto G. Cervello M. Giannitrapani L. Dantona F. Terranova A. Castagnetta L.A. Epidemiology, risk factors, and natural history of hepatocellular carcinoma Ann. N.Y. Acad. Sci. 963 2002 13-20
14. Yu M.C. Yuan J.M. Govindarajan S. Ross R.K. Epidemiology of hepatocellular carcinoma 45 Can. J. Gastroenterol. 14 8 2000 703-709
15. Hemming A.W. Nelson D.R. Reed A.I. Liver transplantation for hepatocellular carcinoma Minerva Chir. 57 5 2002 575-585
16. Neglia A. et al. The risk of cancer among patients with cystic fibrosis N. Engl. J. Med. 332 1995 494-499